NP+PA Perspectives in Dermatology: July-August 2025

Click the cover to access the digital edition of NPPA July-August.

Share:

Recent Articles:

Christopher Bunick, MD, PhD, and James Del Rosso, DO: Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% to Treat Acne Induced by Janus Kinase Inhibitor Treatment: A Case Report
Diego Ruiz Dasilva, MD: Nemolizumab Demonstrates Marked Efficacy in Challenging Chronic Pruritus: A Real-world Multicenter Case
Letters to the Editor: September 2025
Hidradenitis Suppurativa Patients Experience a Significant Musculoskeletal Symptom Burden: A Quality Improvement Initiative Using the IDEOM MSK-Q
Remission of Alopecia Areata Post-colectomy in a Patient with Crohn's Disease
1 2 3 338

Categories:

Recent Articles:

Christopher Bunick, MD, PhD, and James Del Rosso, DO: Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% to Treat Acne Induced by Janus Kinase Inhibitor Treatment: A Case Report
Diego Ruiz Dasilva, MD: Nemolizumab Demonstrates Marked Efficacy in Challenging Chronic Pruritus: A Real-world Multicenter Case
Letters to the Editor: September 2025
Hidradenitis Suppurativa Patients Experience a Significant Musculoskeletal Symptom Burden: A Quality Improvement Initiative Using the IDEOM MSK-Q
Remission of Alopecia Areata Post-colectomy in a Patient with Crohn's Disease
What Are Topical Adaptogens? A Systematic Review and Proposed System to Identify and Categorize Skin Adaptogens in Dermatology
Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% to Treat Acne Induced by Janus Kinase Inhibitor Treatment: A Case Report
Nemolizumab Demonstrates Marked Efficacy in Challenging Chronic Pruritus: A Real-world Multicenter Case Series
Availability of Hats Online in the United States that Meet Sun Protective Recommendations
Systematic Review of the Efficacy and Safety of Topical Glutathione in Dermatology
1 2 3 209

Tags: